HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immediate cardiac allograft failure. ECMO versus total artificial heart support.

Abstract
Optimal support for immediate cardiac allograft failure is unknown. With the introduction of heparin bonded extracorporeal membrane oxygenated circuits, prolonged cardiopulmonary support is possible. The authors report a case that involved 2 days of right atrial to ascending aorta extracorporeal membrane oxygenated support after immediate donor organ failure prevented the patient from exiting bypass. Continued deterioration in cardiac function led to an attempt at conversion to a total artificial heart as a bridge to retransplant. However, this procedure resulted in transbronchial exsanguination and recipient death. The autopsy showed pulmonary thrombosis with infarction and hemorrhage. The authors recommend caution in the use of extracorporeal membrane oxygenated support for patients with immediate and profound graft failure because of the increased risk of stasis thrombosis and pulmonary infarction due to sluggish pulmonary and left atrial blood flow. Instead, institution of total artificial heart or biventricular support may be preferable as the risks of thrombus and infarction are less.
AuthorsR M Adamson, W P Dembitsky, P O Daily, R Moreno-Cabral, J Copeland, R Smith
JournalASAIO journal (American Society for Artificial Internal Organs : 1992) (ASAIO J) 1996 Jul-Aug Vol. 42 Issue 4 Pg. 314-6 ISSN: 1058-2916 [Print] United States
PMID8828790 (Publication Type: Case Reports, Comparative Study, Journal Article)
Chemical References
  • Heparin
Topics
  • Adolescent
  • Coronary Circulation (physiology)
  • Extracorporeal Membrane Oxygenation (adverse effects)
  • Female
  • Heart Failure (mortality, therapy)
  • Heart, Artificial (adverse effects)
  • Hemorrhage (mortality)
  • Heparin (therapeutic use)
  • Humans
  • Infarction (mortality)
  • Male
  • Middle Aged
  • Thrombosis (mortality)
  • Tissue Donors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: